Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Bristol-Myers Squibb
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
For additional information, please contact the BMS oncology clinical trial information service at 855-216-0126 or email MyCancerStudyConnect@emergingmed.com. Please visit www.BMSStudyConnect.com for more information on clinical trial participation.
Histologic/cytologic diagnosis of advanced or metastatic solid tumors
ECOG 0-2
4/6 weeks since prior therapy
You may not be if
Brain metastases
Second primary malignancy
Thromboembolic disease requiring full anticoagulation within 6 months
Inability to swallow or absorb oral therapy
Clareo Health | A Phase I Study to Determine the Effect of Food on Brivanib (BMS-582664)
